Christoffer Nilmén

Associate, Stockholm

Biography

Overview

Christoffer Nilmén is an associate in our Capital Markets practice in Stockholm and joined White & Case in 2019.

Prior to joining White & Case, Christoffer studied at Stockholm University and at University of Auckland. He commenced his career at the Firm as a junior trainee.

Education
LLM
Juris kandidat
Stockholm University
Studies in Commercial Law
University of Auckland
Languages
Swedish
English

Experience

Representation of Morgan Stanley & Co. International plc, Van Lanschot Kempen Wealth Management N.V. and Zonda Partners AB on the directed share issue of approximately SEK 1,112 million (US$ 121 million) by Hansa Biopharma.

Representation of the investment banks ABG Sundal Collier AB and Carnegie Investment Bank AB (publ) on the directed share issue of approximately SEK 270 million by Q-linea AB, an infection diagnostics company. The board of directors of Q-linea AB resolved on a directed share issue of 4,000,000 shares at a subscription price of SEK 67.50 per share, raising gross proceeds of approximately SEK 270 million. The subscription price was determined through an accelerated book building.

Representation of Jefferies International Limited, Carnegie Investment Bank AB (publ), DNB Markets, a part of DNB Bank ASA, Cowen and Company, LLC and Van Lanschot Kempen Wealth Management N.V. on the directed share issue of approximately SEK 1,414 million (USD 144 million) by Oncopeptides, a pharmaceutical company developing drugs for the treatment of cancer.

Representation of MedCap AB (publ), a company that acquires and develops profitable, market leading niche companies in the Nordic life science industry that have the potential to grow internationally, on the directed share issue of approximately SEK 229 million to Swedish and international institutional investors through an accelerated book building procedure. Due to the strong interest from investors, the directed share issue was increased in relation to what was announced in connection with the launch of the transaction.

Representation of Movile Mobile Commerce Holdings, S.L., owner of a group of technology companies, on the European aspects of their sale of (i) Movile Internet Movel S.A., a company providing information technology and services, and (ii) Wavy Global Holdings B.V., a company specializing in helping other companies improve their customers’ experiences through messaging tools and platforms, to TWW Do Brasil S.A. and Sinch Latin America Holding AB.

Representation of FSN Capital Partners on the sale of shares in Bygghemma Group First AB to Swedish and international institutional investors through an accelerated book-building process.

Representation of Carnegie Investment Bank as sole global coordinator and joint bookrunner and Swedbank as joint bookrunner in connection with the EUR 64 million IPO and Nasdaq Helsinki listing of Optomed.

Representation of DNB, Danske Bank and Nordea as managers in connection with the SEK 1,215 million rights issue in Ambea AB, a company listed on Nasdaq Stockholm.

Representation of Carnegie and Nordea in connection with the SEK 4.2 billion IPO and Nasdaq Stockholm listing of Karnov Group.

Representation of Gaming Innovation Group, a company incorporated in Delaware and listed on the Oslo Stock Exchange, in connection with the dual listing of the company's shares on Nasdaq Stockholm.

Representation of ÅF on the recommended cash Tender Offer for all shares in Pöyry. ÅF and Pöyry have signed an agreement to combine the two companies to form a leading European engineering and consulting company.

Representation of EQT on the public cash offer to the shareholders of Karo Pharma.

Representation of European Entertainment Intressenter BidCo AB (EE Intressenter) on the public cash offer to the shareholders in Cherry AB to acquire all Cherry shares at a price of SEK 87 per share.